• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 22 / 2013
        E.g., 1 / 22 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    DEA Promulgates New Rule on Imports and Exports of Listed Chemicals

    April 27, 2007

    On April 9, 2007, the US Drug Enforcement Administration (DEA) promulgated a new rule implementing the Combat Methamphetamine Epidemic Act of 2005 and imposing new reporting requirements on importers, exporters, brokers, and traders of List I and List II chemicals. It becomes effective May 9, 2007.

    The rule imposes several significant new requirements on importers, exporters, brokers and traders of List I and List II chemicals.

    • The rule modifies the conditions under which the 15-day advance notification requirement for imports of listed chemicals is waived. Under the new rule, advanced notification is not required if (1) the importer is considered by DEA to be a regular importer of the listed chemical and (2) the customer is considered by DEA to be a regular customer for the listed chemical.1
    • Importers must provide information to DEA concerning the US purchasing the chemical. This is a new requirement for importers, although exporters have always been required to provide this information.
    • Importers, exporters and brokers or traders involved in an international transaction must file an amended DEA Form 486 if the import, export or international transaction does not occur; if the listed chemical will not be transferred to the person named on the initial Form 486; or if a greater quantity of the chemical than originally indicated will be imported or exported.
    • In addition to filing the initial notification, an importer, exporter, broker or trader must send DEA a return declaration containing specific information about the transaction within 30 days after the exportation or international transaction of a listed chemical is completed.

    To comply with the changes made to the Controlled Substances Act by the Combat Methamphetamine Act of 2005 and other legislation as well as the requirements contained in the new rule, DEA has revised the existing DEA Form 486. For example, the new form has been renamed “Import/Export Declaration for List and List II Chemicals” to more accurately characterize its use. In addition, new fields have been added to the form, including fields for reporting information about the downstream customer and providing the return declaration.

    Because this rulemaking codifies statutory provisions, the rule will become effective, without the opportunity for notice and comment, on May 9, 2007. It is important to note that, under the new rule, effective May 9, 2007, all companies that have been granted regular importer status in the past will be required to provide advance notification of imports, including information about their transferees, even for customers with whom they have done business previously. This will allow the agency to review and approve the customer as a “regular customer” for the chemical being imported.

    The DEA’s rule, as it appears in the Federal Register, can be downloaded here (PDF format).

    For additional information regarding DEA’s new rule – or any DEA-related matter – contact:

    Julie Tierney
    202.828.3427
    tierney.julia@arentfox.com

    1. The new rule retains the exemption from the notification requirement for importers of certain chemicals, including acetone, butanone (or Methyl Ethyl Ketone (MEK)), and toluene. Importers of these chemicals are instead required to file quarterly reports summarizing their imports of these chemicals.

    Related Practices

    FDA Practice (Food & Drug)

    Related Industries

    Life Sciences
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.